FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

41417211000001104: Capecitabine 500mg tablets (Glenmark Pharmaceuticals Europe Ltd) 120 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Feb 2023. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2606151000001110 Capecitabine 500mg tablets (Glenmark Pharmaceuticals Europe Ltd) 120 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2606161000001113 Capecitabine 500mg tablets (Glenmark Pharmaceuticals Europe Ltd) 120 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Capecitabine 500mg tablets (Glenmark Pharmaceuticals Europe Ltd) 120 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Capecitabine 500mg tablets (Glenmark Pharmaceuticals Europe Ltd) 120 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Capecitabine 500mg tablets (Glenmark Pharmaceuticals Europe Ltd) 120 tablet Is a Capecitabine 500mg tablets 120 tablet true Inferred relationship Existential restriction modifier
Capecitabine 500mg tablets (Glenmark Pharmaceuticals Europe Ltd) 120 tablet Has AMP Capecitabine 500mg tablets (Glenmark Pharmaceuticals Europe Ltd) true Inferred relationship Existential restriction modifier
Capecitabine 500mg tablets (Glenmark Pharmaceuticals Europe Ltd) 120 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Capecitabine 500mg tablets (Glenmark Pharmaceuticals Europe Ltd) 120 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Capecitabine 500mg tablets (Glenmark Pharmaceuticals Europe Ltd) 120 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Capecitabine 500mg tablets (Glenmark Pharmaceuticals Europe Ltd) 120 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Capecitabine 500mg tablets (Glenmark Pharmaceuticals Europe Ltd) 120 tablet Has specific active ingredient Capecitabine true Inferred relationship Existential restriction modifier
Capecitabine 500mg tablets (Glenmark Pharmaceuticals Europe Ltd) 120 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Capecitabine 500mg tablets (Glenmark Pharmaceuticals Europe Ltd) 120 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Capecitabine 500mg tablets (Glenmark Pharmaceuticals Europe Ltd) 120 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start